Nuclear receptor subfamily 4 group A member 2 (NURR1) (NR4A2)

Nuclear receptor subfamily 4 group A member 2 (NURR1) is a member of the orphan nuclear receptor family that plays a critical role in the development, survival, and maintenance of midbrain dopaminergic neurons [1, 3]. It functions as a transcription factor, regulating the expression of essential genes such as tyrosine hydroxylase and the dopamine transporter [1, 5]. Reduced Nurr1 activity is associated with the progression of Parkinson's disease and other neurodegenerative conditions, making it a high-priority therapeutic target [3]. Although it lacks a conventional ligand-binding pocket, the ligand-binding domain (LBD) contains unique sites that can be targeted by small-molecule agonists, such as amodiaquine, to enhance its neuroprotective functions [2]. Beyond the central nervous system, Nurr1 is also involved in regulating inflammatory responses in immune cells, suggesting potential applications in autoimmune and inflammatory diseases [4]. Its role in cell proliferation also links it to certain cancers, where it may act as either a tumor suppressor or an oncogene depending on the tissue context [5].

Other names

Nurr1Nuclear receptor related 1 proteinNOTTINURHZF-3NR4A2

Agonism of the Nurr1 receptor to enhance the transcription of genes involved in dopamine synthesis and survival of dopaminergic neurons.